Aurora Cannabis (ACB) Receivables (2018 - 2026)

Aurora Cannabis (ACB) has reported Receivables for 9 consecutive years, with $33.3 million the latest figure, recorded in Q1 2026.

• Quarterly Receivables rose 5.45% year-over-year to $33.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.3 million (up 5.45% YoY) and the FY2026 annual result came in at $33.0 million, up 1.38% from the prior year.
• Receivables advanced to $33.3 million in Q1 2026 per ACB's latest filing, from $31.7 million in the prior quarter.
• Over the last five years, Receivables for ACB reached as high as $37.7 million in Q2 2022 and fell as low as $22.4 million in Q2 2024.
• A 5-year average of $31.6 million and a median of $31.7 million in 2025 frame the typical range for Receivables.
• Annual changes were most pronounced in 2022 — Receivables plunged 47.68% — and 2025, when it rose 26.13%.
• Year by year, Receivables stood at $35.2 million in 2022, then dropped by 9.63% to $31.8 million in 2023, then climbed by 11.4% to $35.4 million in 2024, then fell by 10.61% to $31.7 million in 2025, then climbed by 4.95% to $33.3 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $33.3 million, $31.7 million, and $34.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.